RNL Bio
1596-7 Bongcheon-Dong
Gwanak-Gu
Seoul
151-835
Tel: 82-2-874-1355
Fax: 82-2-874-1356
Website: http://www.rnl.co.kr/eng/
15 articles about RNL Bio
-
RNL Bio and Human Biostar to Offer Direct-to-Consumer Adult Stem Cell Banking in the United States
5/21/2013
-
RNL Bio Files IND to Commence Phase II Clinical Trial of RNL-JointStem for Osteoarthritis in the United States
5/2/2013
-
RNL Bio Filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
2/11/2013
-
RNL Bio Study Shows Stem Cells May Prevent and Cure Alzheimer's
9/27/2012
-
RNL Bio, a South Korean Adult Stem Cell Firm, Introduces Its Autologous Stem Cell Therapeutics in Turkey to Treat Patients With Various Intractable Diseases
9/14/2012
-
RNL Bio Release: New Method Helps Stem Cells Find Damaged Tissue Better
11/17/2011
-
RNL Bio Release: American Orthopedic Spine Surgeon Successfully Treated for Autoimmune Arthritis with His Own Stem Cells
1/27/2011
-
RNL Bio and stART Licensing, Inc. Settled Patent Disputes and Concluded a License Agreement
1/12/2010
-
RNL Bio Rescues a College Student from Autoimmune Hearing Loss
11/4/2009
-
South Korean Bio-Firm, RNL Bio Says Dog Cloning to be Cheaper
1/29/2009
-
RNL Bio Scientists Clone Five Puppies From Dead Pet
8/6/2008
-
RNL Bio Granted Exclusive License for Dog Cloning from Seoul National University
6/26/2008
-
Real Clone Wars: International Dog-Fight over Cloning Rights Between BioArts International & RNL Bio
6/19/2008
-
South Korea Firm RNL Bio Says It Clones Cancer-Sniffing Dogs
6/17/2008
-
South Korean Biotech Company RNL Bio Receives First Order for Pet Clone
2/18/2008